Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Innohep 12,000units/0.6ml inj pre-filled syringes
0208010W0BCAMAS
|
Innohep | Tinzaparin sodium | Cardiovascular System | 20 |
|
Innohep 14,000units/0.7ml inj pre-filled syringes
0208010W0BCAEAI
|
Innohep | Tinzaparin sodium | Cardiovascular System | 19 |
|
Innohep 8,000units/0.4ml inj pre-filled syringes
0208010W0BCANAT
|
Innohep | Tinzaparin sodium | Cardiovascular System | 11 |
|
Innohep 10,000units/0.5ml inj pre-filled syringes
0208010W0BCAGAK
|
Innohep | Tinzaparin sodium | Cardiovascular System | 10 |
|
Innohep 18,000units/0.9ml inj pre-filled syringes
0208010W0BCAFAJ
|
Innohep | Tinzaparin sodium | Cardiovascular System | 10 |
|
Innohep 16,000units/0.8ml inj pre-filled syringes
0208010W0BCALAR
|
Innohep | Tinzaparin sodium | Cardiovascular System | 6 |
|
Innohep 2,500units/0.25ml inj pre-filled syringes
0208010W0BCAKAQ
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Innohep 20,000units/2ml solution for injection vials
0208010W0BCAJAN
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Innohep 3,500units/0.35ml inj pre-filled syringes
0208010W0BCAHAL
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Innohep 4,500units/0.45ml inj pre-filled syringes
0208010W0BCAIAM
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Innohep 40,000units/2ml solution for injection vials
0208010W0BCACAF
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.